We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
Columbia engineers have developed nanoparticles and ultra-thin catheters for targeted delivery into the lungs, allowing for enhanced control of therapeutics.
